Menu Close

Trending

Astellas files menopause drug fezolinetant in US, setting up Feb verdict
Frontiers Steering Committee spotlight: Megan Coder
Endo files for bankruptcy as it agrees opioid settlement
bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval
Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise

Webinars in home page

 
IQVIA Webinar

Debates/ Market Access/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Medical Informatics and Rare Disease: a bridge between two worlds

, , , 0 Comment

With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the

X
Medical Informatics and Rare Disease: a bridge between two worlds
https://pharmaphorum.com/webinars/medical-informatics-bridge-between-two-worlds-iqvia/
 
IQVIA Webinar

Debates/ Market Access/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

ICSs – an opportunity to improve Patient & Market Access at a local level

, , , , , 0 Comment

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in

X
ICSs – an opportunity to improve Patient & Market Access at a local level
https://pharmaphorum.com/webinars/integrated-care-systems-opportunity-to-improve-patient-market-access/
 
communication strategy

Digital/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Is your digital communication strategy up to par?

, , , 0 Comment

Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges

X
Is your digital communication strategy up to par?
https://pharmaphorum.com/webinars/is-your-digital-communication-strategy-up-to-par/
 
Debiopharm-Webinar-Image-1200x675-Text-NEW2

Debates/ Debates & Insight/ Digital/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

The Digital Health Start-up Journey: Series A to scale-up

, , , 0 Comment

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on

X
The Digital Health Start-up Journey: Series A to scale-up
https://pharmaphorum.com/webinars/the-digital-health-start-up-journey-series-a-to-scale-up/
 
digital transformation

Debates/ Digital/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Preparing industry leaders for digital transformation

, , , , , 0 Comment

Digital transformation is taking root in every major industry, and healthcare and life sciences are no exception. In

X
Preparing industry leaders for digital transformation
https://pharmaphorum.com/webinars/preparing-industry-leaders-for-digital-transformation/
 
Print

Debates/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

How new data capabilities can supercharge clinical research

, , , 0 Comment

The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s

X
How new data capabilities can supercharge clinical research
https://pharmaphorum.com/webinars/how-new-data-capabilities-can-supercharge-clinical-research/
 
Sensyne Health Webinar

Debates & Insights/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand

Synthetic control arms in clinical trials: Making it happen

, , , , , 0 Comment

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges

X
Synthetic control arms in clinical trials: Making it happen
https://pharmaphorum.com/webinars/synthetic-control-arms-in-clinical-trials-making-it-happen/
1 2 3 4 ›»

Login

CONTINUE TO SITE >
X
Close in 10 seconds